| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/11/2023 | -7.41% | Cantor Fitzgerald | → $0.15 | Reinstates | → Neutral |
| 07/13/2022 | 1134.57% | Roth Capital | $13 → $2 | Downgrades | Buy → Neutral |
| 07/13/2022 | 1134.57% | Cantor Fitzgerald | $30 → $2 | Downgrades | Overweight → Neutral |
| 07/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 09/10/2021 | 5455.56% | Jefferies | $37 → $9 | Downgrades | Buy → Hold |
| 09/09/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 09/09/2021 | 17183.95% | HC Wainwright & Co. | $36 → $28 | Maintains | Buy |
| 08/13/2021 | 14714.81% | Credit Suisse | $25 → $24 | Maintains | Outperform |
| 08/10/2021 | 19653.09% | Roth Capital | $37 → $32 | Maintains | Buy |
| 06/11/2021 | 17183.95% | Credit Suisse | → $28 | Initiates Coverage On | → Outperform |
| 05/07/2021 | 18418.52% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
| 04/12/2021 | 22122.22% | HC Wainwright & Co. | $34 → $36 | Reiterates | → Buy |
| 12/23/2020 | 21504.94% | National Securities Corporation | → $35 | Initiates Coverage On | → Buy |
| 12/22/2020 | 16566.67% | Jefferies | → $27 | Initiates Coverage On | → Buy |
| 10/21/2020 | 15332.1% | Cantor Fitzgerald | → $25 | Initiates Coverage On | → Overweight |
| 10/14/2020 | 19035.8% | HC Wainwright & Co. | → $31 | Initiates Coverage On | → Buy |
| 10/01/2020 | 15332.1% | Roth Capital | → $25 | Initiates Coverage On | → Buy |
What is the target price for Humanigen (HGEN)?
The latest price target for Humanigen (NASDAQ: HGEN) was reported by Cantor Fitzgerald on January 11, 2023. The analyst firm set a price target for $0.15 expecting HGEN to fall to within 12 months (a possible -7.41% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humanigen (HGEN)?
The latest analyst rating for Humanigen (NASDAQ: HGEN) was provided by Cantor Fitzgerald, and Humanigen their neutral rating.
When is the next analyst rating going to be posted or updated for Humanigen (HGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen was filed on January 11, 2023 so you should expect the next rating to be made available sometime around January 11, 2024.
Is the Analyst Rating Humanigen (HGEN) correct?
While ratings are subjective and will change, the latest Humanigen (HGEN) rating was a with a price target of $0.00 to $0.15. The current price Humanigen (HGEN) is trading at is $0.16, which is out of the analyst's predicted range.